The rapid increase in biopharmaceutical approvals and sales indicates their tremendous opportunities in the coming years. Innovative software solutions play an essential role in unlocking that potential. Learn more about how ACD/Labs brings chemical intelligence to biopharmaceutical research in this blog post.
Richard Lee discusses the global trend around the development of machine learning (ML) and artificial intelligence (AI) capabilities. As utilization of ML/AI continues to grow, R&D organizations will likely continue to focus on how to normalize data into a format that can be fed into a ML/AI framework.